Viewing Gene With Clinical Trials Data

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Report Bug Request Feature
Gene Data From HGNC: https://www.genenames.org/download/statistics-and-files/
Symbol: CD80
Name: CD80 molecule
Location: 03q13.33
Locus Group: protein-coding gene
Gene Type: Protein Coding
Locus Type: gene with protein product
ID+ Clinical Trials CompTox DrugMatrix Conditions Design Enrollment Locations Outcomes
Clinical Trials Data: https://classic.clinicaltrials.gov/api/gui/ref/download_all

Clinical Studies

NCT Number Status Brief Title View
NCT01339481 A Study to Assess the Receptor Occupancy of CD86 and CD80 in Subjects With Rheumatoid Arthritis Initiating Abatacept View
NCT03051906 Durvalumab Cetuximab and Radiotherapy in Head Neck Cancer View
NCT00117975 Rituximab and Galiximab in Treating Patients With Stage II Stage III or Stage IV Non-Hodgkins Lymphoma View
NCT05242354 Macrophage Markers in Periodontal and Peri-implant Health and Disease View
NCT01127074 Vaccination of Metastatic Breast Cancer Patients With a CD80-modified Allogeneic Cancer Cell Line KS2422 View
NCT04158128 The Clinical Implications of Immune Checkpoint Pathways in PCNSL View
NCT00003184 Vaccine Therapy in Treating Women With Metastatic Breast Cancer View
NCT01265368 A Clinical Study to Assess Safety and Efficacy of a Tumor Vaccine in Patients With Advanced Renal Cell Carcinoma ASET View
NCT00515983 Vaccination of Melanoma Patients With Dendritic Cells Loaded With Allogeneic Apoptotic-Necrotic Melanoma Cells View
NCT00445913 Autologous Dendritic Cell Therapy for Type 1 Diabetes Suppression A Safety Study View
NCT00516217 Galiximab in Treating Patients With Relapsed or Refractory Hodgkins Lymphoma View
NCT00684242 Lenalidomide Revlimid for the Treatment of Refractory Cancer Pain View
NCT00718250 Lentivirus Transduced Acute Myeloid Leukaemia Blasts Expressing B71 CD80 and IL-2 View
NCT05468866 The Expression of Immune Checkpoint CD28 rs1980422-related Single-nucleotide Polymorphisms in the Primary Immune Thrombocytopenia View
NCT03799744 SafetyTolerabilityand Efficacy of VCN-01 With Durvalumab in RM Head and Neck Squamous Cell Carcinoma View
NCT00048555 Safety and Efficacy of IDEC-114 in Combination With Rituxan in the Treatment of Non-Hodgkins Lymphoma View
NCT05824975 A Study to Evaluate the Safety and Therapeutic Activity of GI-102 in Patients With Advanced Solid Tumors View
NCT01222039 Multicenter Clinical Trial for the Evaluation of Mesenchymal Stem Cells From Adipose Tissue in Patients With Chronic Graft Versus Host Disease View
NCT04977453 GI-101 As a Single Agent or in Combination with Pembrolizumab Lenvatinib or Local Radiotherapy in Advanced Solid Tumors View
NCT00575068 Safety and Efficacy of IDEC-114 in the Treatment of Non-Hodgkins Lymphoma View
NCT00704119 Study Evaluating the Pharmacokinetic Profile of RhuDex in a Tablet Formulation View
NCT03110445 CancerTestis Antigen Immunotherapy Phase I Study With 740-CTA Vaccinia Virus View
NCT03162224 Safety and Efficacy of MEDI0457 and Durvalumab in Participants With Human Papilloma Virus HPV Associated RecurrentMetastatic Head and Neck Cancer View
NCT03980639 Abatacept and the Risk of Cancer a Case Non-case Analysis in VigiBase View